May 14, 2021 10:28 AMWASHINGTON (REUTERS) - Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20 per cent the day after it announced on April 25 that it had "completed the first patient enrolment and dosing" in a late-stage US clinical trial of its experimental Covid-19 treatment.